Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Oculogica is a pioneering neuro-diagnostic company dedicated to revolutionizing the assessment of brain injuries. Their flagship product, the EyeBOX®, is the first FDA-cleared, baseline-free medical device that provides an objective aid in the diagnosis of concussion. Utilizing advanced eye-tracking technology, Oculogica aims to provide clinicians with rapid, accurate, and non-invasive tools to improve patient outcomes in conditions like traumatic brain injury (TBI). The company was founded by Dr. Uzma Samadani, a neurosurgeon, with a mission to address the unmet need for objective biomarkers in brain health.
Serves as the primary center for Oculogica's corporate operations, research and development initiatives, and strategic business management.
Located in a dynamic commercial district of Manhattan, providing access to a rich ecosystem of medical technology and research institutions. Modern office facilities equipped for technology development and corporate functions.
Oculogica likely fosters a culture of innovation, scientific rigor, and collaboration, driven by its mission to improve neuro-diagnostics. There is an emphasis on impact-driven work within the medical technology field.
The New York City location provides strategic advantages, including proximity to leading medical centers, research universities, a vibrant talent pool in technology and healthcare, and access to investment communities.
Oculogica is primarily focused on the United States market, where its EyeBOX® device has received FDA clearance. The company has also achieved CE Mark certification, enabling expansion into European markets. While its main operations are in the US, Oculogica engages in research collaborations and clinical studies that may have an international scope, aiming to expand the reach of its neuro-diagnostic technology globally.
134 W 29th St, 6th Floor
New York
NY
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Oculogica' leadership includes:
Oculogica has been backed by several prominent investors over the years, including:
Over the past year, Oculogica has made a key appointment in its commercial leadership by bringing in a new Chief Commercial Officer to spearhead market strategy and drive revenue growth, following the departure of the previous CCO.
Discover the tools Oculogica uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Oculogica commonly utilizes the email format combining the first initial with the last name (e.g., jdoe@oculogica.com). While other formats might exist within the organization, this pattern is frequently observed for companies in the medical technology sector.
flast@oculogica.com
Format
jsmith@oculogica.com
Example
85%
Success rate
PR Newswire • October 17, 2023
Oculogica announced it has received CE Mark certification for its EyeBOX® device, enabling the commercialization of the objective concussion diagnostic tool in European Union countries and other regions that recognize the CE Mark. This marks a significant step in the company's global expansion efforts....more
PR Newswire • July 12, 2023
Oculogica announced the publication of results from its pivotal EYE-D study in the Journal of Neurosurgery: Pediatrics. The study demonstrated the EyeBOX's ability to aid in the diagnosis of concussion in pediatric patients, further validating its utility in a critical patient population....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Oculogica, are just a search away.